Dyne Therapeutics, Inc. · NASDAQ:DYN

Kerr Douglas received 8,000 Dyne Therapeutics, Inc. shares as an award (Form 4)

Traded Oct 20, 2026 · Filed Oct 22, 2026

On Oct 20, 2026, Kerr Douglas (Head of R&D and CMO) received 8,000 Dyne Therapeutics, Inc. shares as an award, leaving 170,564 shares. Filed Oct 22, 2026 (Form 4).

Awarded: 8,000 shares
Holding after: 170,564 shares
Trading plan: No
Role: Head of R&D and CMO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Oct 20, 2026	Common Stock	Award	8,000		170,564	Direct

Source

Download original · View original at SEC

Related